LENVATINIB IMPROVES PROGRESSION FREE SURVIVAL IN PATIENTS WITH INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA AFTER TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION

被引：0
|
作者：
Shimose, Shigeo [1 ]
Kawaguchi, Takumi [1 ]
Iwamoto, Hideki [1 ]
Nakano, Masahito [1 ]
Takashi, Niizeki [1 ]
Shirono, Tomotake [1 ]
Tanaka, Masatoshi [2 ]
Koga, Hironori [1 ]
Torimura, Takuji [1 ]
机构：
[1] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka, Japan
[2] Yokokura Hosp, Miyama, Fukuoka, Japan
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
367
引用
收藏
页码：233A / 234A
页数：2
相关论文
共 50 条
  • [31] Rhabdomyolysis Developing After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
    Kunishige Matake
    Tsuyoshi Tajima
    Kengo Yoshimitsu
    Hiroyuki Irie
    Hitoshi Aibe
    Atsushi Sugitani
    Hiroshi Honda
    CardioVascular and Interventional Radiology, 2009, 32 : 1284 - 1287
  • [32] Necrotizing pancreatitis after transcatheter arterial chemoembolization for hepatocellular carcinoma
    Ozcinar, Beyza
    Guven, Koray
    Poyanli, Arzu
    Ozden, Ilgin
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2009, 15 (01) : 36 - 38
  • [33] Transcatheter arterial chemoembolization confers survival benefit in patients with a spontaneously ruptured hepatocellular carcinoma
    Kim, Jong Yeon
    Lee, June Sung
    Oh, Dong-Hoon
    Yim, Yun Hyuk
    Lee, Hyo Keun
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 24 (06) : 640 - 645
  • [34] Lenvatinib prolongs the progression-free survival time of patients with intermediate-stage hepatocellular carcinoma refractory to transarterial chemoembolization: A multicenter cohort study using data mining analysis
    Shimose, Shigeo
    Kawaguchi, Takumi
    Tanaka, Masatoshi
    Iwamoto, Hideki
    Miyazaki, Ken
    Moriyama, Etsuko
    Suzuki, Hiroyuki
    Niizeki, Takashi
    Shirono, Tomotake
    Nakano, Masahito
    Suga, Hideya
    Yamaguchi, Taizo
    Yokokura, Yoshinori
    Noguchi, Kazunori
    Koga, Hironori
    Torimura, Takuji
    ONCOLOGY LETTERS, 2020, 20 (03) : 2257 - 2265
  • [35] Efficacy of combination therapy with transcatheter arterial chemoembolization and radiofrequency ablation for intermediate-stage hepatocellular carcinoma
    Endo, Kei
    Kuroda, Hidekatsu
    Oikawa, Takayoshi
    Okada, Yohei
    Fujiwara, Yudai
    Abe, Tamami
    Sato, Hiroki
    Sawara, Kei
    Takikawa, Yasuhiro
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (12) : 1575 - 1583
  • [36] Biliary complications after transcatheter arterial chemoembolization for hepatocellular carcinoma
    Lee, Yoon Suk
    Kim, Kyung-Ah
    INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION, 2020, 9 (01): : 27 - 30
  • [37] Rhabdomyolysis Developing After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
    Matake, Kunishige
    Tajima, Tsuyoshi
    Yoshimitsu, Kengo
    Irie, Hiroyuki
    Aibe, Hitoshi
    Sugitani, Atsushi
    Honda, Hiroshi
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2009, 32 (06) : 1284 - 1287
  • [38] THE IMPACT OF INTERPROCEDURE RADIOLOGICAL CHARACTERISTICS TO THE OUTCOMES OF INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA RECEIVING TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
    Lee, Shao-Wu
    Cheng, Yu-Chi
    Yen, Chieh-Ling
    Lee, Teng-Yu
    GUT, 2022, 71 : A72 - A73
  • [39] TRANSARTERIAL CHEMOEMBOLIZATION IN THE INTERMEDIATE STAGE OF HEPATOCELLULAR CARCINOMA: SURVIVAL ANALYSIS
    Tajibaev, T. K.
    Medeubekov, U. Sh
    Chormanov, A. T.
    Sagatov, I. Y.
    Kaniev, Sh A.
    Issamatov, B. K.
    Baimakhanov, B. B.
    NEW ARMENIAN MEDICAL JOURNAL, 2019, 13 (02): : 111 - 114
  • [40] Prognostic Score predicting overall survival of Patients with Intermediate Stage of Hepatocellular Carcinoma after Transarterial Chemoembolization
    Jarupongprapa, Saharat
    Nimanong, Supot
    Chainuvati, Siwaporn
    Charatcharoenwitthaya, Phunchai
    Tanwandee, Tawesak
    Chotiyaputta, Watcharasak
    HEPATOLOGY, 2015, 62 : 444A - 445A
12345